Skyrizi 180 MG/1.2 ML on-body 1.2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5F5E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,467 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 180 MG/1.2 ML on-body auto-injector pharmaceutical product, with an ultimate completion date of January 26, 2026. The award, issued on January 2, 2026, was made without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026.
The SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This contract vehicle supports customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order for SKYRIZI, a specialty pharmaceutical for dermatological treatment, exemplifies the company's role as a primary vendor fulfilling critical medical commodity needs for federal defense and healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F5F5E?
SPE2DR26F5F5E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26F5F5E worth?
The government has obligated $12,467 on SPE2DR26F5F5E.
Is contract SPE2DR26F5F5E an order under another contract?
Yes. SPE2DR26F5F5E is a delivery order under SPE2DR25D3306, an indefinite delivery contract.
Was contract SPE2DR26F5F5E competed?
The extent of competition for SPE2DR26F5F5E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award